JP2002538771A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002538771A5 JP2002538771A5 JP2000587730A JP2000587730A JP2002538771A5 JP 2002538771 A5 JP2002538771 A5 JP 2002538771A5 JP 2000587730 A JP2000587730 A JP 2000587730A JP 2000587730 A JP2000587730 A JP 2000587730A JP 2002538771 A5 JP2002538771 A5 JP 2002538771A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- fragment
- monoclonal antibody
- monoclonal
- humanized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21279398A | 1998-12-16 | 1998-12-16 | |
| US11253298P | 1998-12-16 | 1998-12-16 | |
| US09/212,793 | 1998-12-16 | ||
| US60/112,532 | 1998-12-16 | ||
| PCT/US1999/030345 WO2000035409A2 (en) | 1998-12-16 | 1999-12-16 | Hiv-i fusion inhibition compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002538771A JP2002538771A (ja) | 2002-11-19 |
| JP2002538771A5 true JP2002538771A5 (https=) | 2007-02-15 |
Family
ID=26810060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000587730A Ceased JP2002538771A (ja) | 1998-12-16 | 1999-12-16 | Ｈｉｖ−１の融合及び付着の相乗的阻害、そのための組成物および抗体 |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP1144006B1 (https=) |
| JP (1) | JP2002538771A (https=) |
| AT (1) | ATE375802T1 (https=) |
| AU (3) | AU773175B2 (https=) |
| CA (1) | CA2355607A1 (https=) |
| CY (1) | CY1107858T1 (https=) |
| DE (1) | DE69937369T2 (https=) |
| DK (1) | DK1144006T3 (https=) |
| ES (1) | ES2296416T3 (https=) |
| HK (1) | HK1041207B (https=) |
| MX (1) | MXPA01006097A (https=) |
| PT (1) | PT1144006E (https=) |
| WO (1) | WO2000035409A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0847452B1 (en) | 1995-06-07 | 2009-04-01 | Progenics Pharmaceuticals, Inc. | Monoclonal antibody for inhibiting hiv-1 envelope glycoprotein mediated membrane fusion |
| US7118859B2 (en) | 1996-01-17 | 2006-10-10 | Progenics Pharmaceuticals, Inc. | Methods for inhibiting HIV-1 infection |
| AU2265701A (en) * | 1999-12-16 | 2001-06-25 | Tanox, Inc. | Anti-hiv-1 conjugates for treatment of hiv disease |
| US7138119B2 (en) | 2000-09-15 | 2006-11-21 | Progenics Pharmaceuticals, Inc. | Compositions and methods for inhibition of HIV-1 infection |
| US7060273B2 (en) | 2001-04-06 | 2006-06-13 | Progenics Pharmaceuticals, Inc. | Methods for inhibiting HIV-1 infection |
| US20020146415A1 (en) * | 2001-04-06 | 2002-10-10 | Olson William C. | Methods for inhibiting HIV-1 infection |
| US20060078537A1 (en) * | 2001-12-21 | 2006-04-13 | Matthias Mack | Mono-and dual chemokine/cytokine constructs |
| DE60324664D1 (de) * | 2002-02-22 | 2008-12-24 | Pdl Biopharma Inc | Anti-ccr5 antikörper |
| US7122185B2 (en) | 2002-02-22 | 2006-10-17 | Progenics Pharmaceuticals, Inc. | Anti-CCR5 antibody |
| TW200720289A (en) | 2005-04-01 | 2007-06-01 | Hoffmann La Roche | Antibodies against CCR5 and uses thereof |
| JP2009525301A (ja) * | 2006-01-30 | 2009-07-09 | エフ．ホフマン−ラ ロシュ アーゲー | Ｈｉｖを処置するための相乗的組成物 |
| TW200817438A (en) | 2006-08-17 | 2008-04-16 | Hoffmann La Roche | A conjugate of an antibody against CCR5 and an antifusogenic peptide |
| AU2007286451A1 (en) | 2006-08-17 | 2008-02-21 | F. Hoffmann-La Roche Ag | A conjugate of an antibody against CCR5 and an antifusogenic peptide |
| KR20090052358A (ko) | 2006-09-29 | 2009-05-25 | 에프. 호프만-라 로슈 아게 | Ｃｃｒ5 에 대한 항체 및 이의 용도 |
| CL2008000707A1 (es) | 2007-03-13 | 2008-09-22 | Hoffmann La Roche | Conjugado de polipeptidos antifusogenicos y polipeptidos derivados de la cabeza globular del factor del complemento c1q; composicion farmaceutica que lo comprende; su uso para tratar infecciones viricas; y metodo de produccion. |
| EP2741777B1 (en) | 2011-08-12 | 2017-01-18 | INSERM - Institut National de la Santé et de la Recherche Médicale | Methods and pharmaceutical compositions for treatment of pulmonary hypertension |
| US11629196B2 (en) | 2020-04-27 | 2023-04-18 | Incelldx, Inc. | Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3375697A (en) * | 1996-05-28 | 1998-01-05 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Cc chemokine receptor 5, antibodies thereto, transgenic animals |
| AU735460B2 (en) * | 1996-06-14 | 2001-07-12 | Aaron Diamond Aids Research Center, The | Uses of a chemokine receptor for inhibiting HIV-1 infection |
| US6528625B1 (en) * | 1996-10-28 | 2003-03-04 | Millennium Pharmaceuticals, Inc. | Anti-CCR5 antibodies and kits comprising same |
-
1999
- 1999-12-16 ES ES99966466T patent/ES2296416T3/es not_active Expired - Lifetime
- 1999-12-16 EP EP99966466A patent/EP1144006B1/en not_active Expired - Lifetime
- 1999-12-16 WO PCT/US1999/030345 patent/WO2000035409A2/en not_active Ceased
- 1999-12-16 PT PT99966466T patent/PT1144006E/pt unknown
- 1999-12-16 AU AU21996/00A patent/AU773175B2/en not_active Ceased
- 1999-12-16 HK HK02102467.8A patent/HK1041207B/en not_active IP Right Cessation
- 1999-12-16 AT AT99966466T patent/ATE375802T1/de not_active IP Right Cessation
- 1999-12-16 DK DK99966466T patent/DK1144006T3/da active
- 1999-12-16 MX MXPA01006097A patent/MXPA01006097A/es not_active IP Right Cessation
- 1999-12-16 EP EP08173136A patent/EP2088158A3/en not_active Withdrawn
- 1999-12-16 CA CA002355607A patent/CA2355607A1/en not_active Abandoned
- 1999-12-16 DE DE69937369T patent/DE69937369T2/de not_active Expired - Lifetime
- 1999-12-16 JP JP2000587730A patent/JP2002538771A/ja not_active Ceased
-
2004
- 2004-08-20 AU AU2004205164A patent/AU2004205164A1/en not_active Abandoned
- 2004-08-20 AU AU2004205165A patent/AU2004205165A1/en not_active Abandoned
-
2008
- 2008-01-17 CY CY20081100062T patent/CY1107858T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002538771A5 (https=) | ||
| US11987635B2 (en) | Anti-4-1BB antibodies and methods of making and using thereof | |
| JP2022031635A5 (https=) | ||
| KR102100467B1 (ko) | Ｃｄ33 항체 및 암을 치료하기 위한 이의 용도 | |
| JP6515111B2 (ja) | 新規の抗クローディン抗体および使用方法 | |
| US8613903B2 (en) | Humanized L243 antibodies | |
| AU2018295119B2 (en) | Multi-specific antibodies and methods of making and using thereof | |
| EP0515571B1 (en) | Hybrid reagents capable of selectively releasing molecules into cells | |
| JP2020002172A5 (https=) | ||
| JP2008540447A5 (https=) | ||
| WO2015081158A1 (en) | Method of treating hiv by disrupting pd-1/pd-l1 signaling | |
| HRP20170342T1 (hr) | Metode i sastavi za povećanje učinkovitosti terapijskih protutijela koristeći tvari koje potenciraju nk stanice | |
| EA031872B1 (ru) | Гуманизированное антитело к cd40, его применение, фармацевтическая композиция, содержащая это антитело, и выделенный полинуклеотид, кодирующий его | |
| JP2013539352A5 (https=) | ||
| JP2015523961A5 (https=) | ||
| WO2002022077A3 (en) | Compositions and methods for inhibition of hiv-1 infection | |
| JP2025183307A5 (https=) | ||
| WO2003078468A3 (de) | Verwendung einer an cd28 bindenden wirksubstanz zur herstellung einer pharmazeutischen zusammensetzung | |
| EP4527408A3 (en) | Claudin-6 antibodies and drug conjugates | |
| HRP20230027T1 (hr) | Konjugati protutijela s lijekom i njihova upotreba u liječenju raka | |
| EP4271713A1 (en) | B7h4-targeted antibody-drug conjugates and methods of use thereof | |
| HRP20171580T1 (hr) | Ljudska monoklonska protutijela koja su specifična za protein e denga virusa serotipa 1 i njihova upotreba | |
| JP2005505256A5 (https=) | ||
| AU2016355206A1 (en) | Novel anti-EMR2 antibodies and methods of use | |
| RU2017145662A (ru) | Моноклональные антитела и способы их применения |